Seattle Genetics(美國(guó))

Seattle Genetics

美國(guó)SeattleGenetics www.seagen.comSeattleGenetics公司是美國(guó)的一家研發(fā)治療腫瘤和免疫類疾病的單克隆抗體藥物的生物技術(shù)公司。該公司在抗體偶聯(lián)技術(shù)方面比較有優(yōu)勢(shì)，正在研發(fā)多種偶聯(lián)抗癌劑的抗體藥物。AtSeattleGenetics,wearecommittedtodevelopinginnovativeantibody-basedtherapiesthati mproveclinicaloutcomesforpatientswithcancerandautoimmunediseases.Wearededicatedtoaddressingunmetmedicalneed,andstrivetoachievethatgoalthroughanunwaveringcommitmenttoexcellenceinclinicaldevelopment.FocusingonClinicalDevelopmentSeattleGeneticsisaclinicalstagebiotechnologycompanyadvancingabroadproductpipelineofantibody-basedtherapies.Ourleadprogram,brentuximabvedotin(SGN-35),isinapivotaltrialunderaSpecialProtocolAssessmentwiththeFDAforpatientswithrelapsedorrefractoryHodgkinlymphoma.BrentuximabvedotinisempoweredbySeattleGenetics'proprietaryantibody-drugconjugate(ADC)technology.Inaddition,weareconductingclinicaltrialswithfourotherproduct